Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

The 2022 ASCO Annual Meeting, held in Chicago, IL showcased the latest research in cancer care. This year's programme featured several sessions complementing the meeting's theme: Advancing Equitable Cancer Care Through Innovation. Key trial updates include the practice-changing results of DESTINY-Breast04, PARADIGM as well as the novel KRASG12C inhibitor adagrasib, in non-small cell lung cancer.
View all videos

ASCO 2022

American Society for Clinical Oncology Annual Meeting 2022
03–07 June 2022 | Chicago, IL, and Online

📢With the 2024 @ASCO Annual Meeting only 3 weeks away, we’re gearing up to provide you exclusive, up-to-date coverage!

Join us at http://VJOncology.com for key updates on #Oncology innovation and research!

#ASCO24

May is #BladderCancerMonth24 and watch out for our weekly podcast on our website this Friday with our special guest Rob Jones, who will talk on:

⭐#Bladdercancer management in the UK
⭐Improving 1L treatment in BC
⭐Survivorship challenges

Here's a 30 sec preview🎙️

#blcsm

Join us for our Post-ASCO 2024 Highlights 📣🩸

Featuring presentations & panel discussions on selected abstracts from #ASCO 2024 🔦

Agendas available soon 📝

REGISTER 👉 https://www.vjoncology.com/feature/post-asco-2024-highlights/

#ASCO24 @DrSanjayPopat @tompowles1 @stolaney1 @LizzySmyth1

⏰ #ESMOBreast24 is just a week away!

We’re excited to bring you the latest news in #breastcancer at http://VJOncology.com, and follow us @VJOncology for exclusive interviews with experts, podcasts, and more!

@‌myESMO #bcsm

Load More

ASCO 2022

American Society for Clinical Oncology Annual Meeting 2022
03–07 June 2022 | Chicago, IL, and Online
The 2022 ASCO Annual Meeting, held in Chicago, IL showcased the latest research in cancer care. This year's programme featured several sessions complementing the meeting's theme: Advancing Equitable Cancer Care Through Innovation. Key trial updates include the practice-changing results of DESTINY-Breast04, PARADIGM as well as the novel KRASG12C inhibitor adagrasib, in non-small cell lung cancer.
View all videos

📢With the 2024 @ASCO Annual Meeting only 3 weeks away, we’re gearing up to provide you exclusive, up-to-date coverage!

Join us at http://VJOncology.com for key updates on #Oncology innovation and research!

#ASCO24

May is #BladderCancerMonth24 and watch out for our weekly podcast on our website this Friday with our special guest Rob Jones, who will talk on:

⭐#Bladdercancer management in the UK
⭐Improving 1L treatment in BC
⭐Survivorship challenges

Here's a 30 sec preview🎙️

#blcsm

Join us for our Post-ASCO 2024 Highlights 📣🩸

Featuring presentations & panel discussions on selected abstracts from #ASCO 2024 🔦

Agendas available soon 📝

REGISTER 👉 https://www.vjoncology.com/feature/post-asco-2024-highlights/

#ASCO24 @DrSanjayPopat @tompowles1 @stolaney1 @LizzySmyth1

⏰ #ESMOBreast24 is just a week away!

We’re excited to bring you the latest news in #breastcancer at http://VJOncology.com, and follow us @VJOncology for exclusive interviews with experts, podcasts, and more!

@‌myESMO #bcsm

Load More